xxii CONTRIBUTORS
Joel Elkes, M.D., is Professor Emeritus at the Johns Hopkins University,
the University of Louisville, and McMaster University in Hamilton,
Ontario. He came to the NIMH in 1957 to found the Clinical Neuro
pharmacology Research Center at St. Elizabeths Hospital in Washington,
D.C., and, in 1963, moved on to the Johns Hopkins University where he
served as Henry Phipps Professor and Director of the Department of
Psychiatry and Behavioral Sciences until 1975. His work has contri
buted to the founding of the new science of psychopharmacology, a
science dealing with the play of chemical influences on mental life, and
the place of drugs in the management and treatment of mental illness.Ingrid G. Farreras, Ph.D., is Assistant Professor of Psychology at Hood
College in Frederick, Maryland. She has also been a DeWitt Stetten, Jr.,
Memorial Fellow in the History of Biomedical Sciences and Technology
at the Office of NIH History since 2001. Her research interests include
the efforts to professionalize the field of clinical psychology during the
first half of the twentieth century and the history of David Shakow’s
NIMH Laboratory of Psychology. She has a chapter in the forthcoming
book by Wade E. Pickren and Stanley F. Schneider (Eds.): Psychology
and the National Institute of Mental Health: A Historical Analysis of
Science, Practice, and Policy (Washington, D. C.: American Psychological
Association Press.)Sid Gilman, M.D., is the William J. Herdman Professor and Chair of
the Department of Neurology at the University of Michigan Medical
School, where he has been since 1977. He is also Director of the Univer
sity of Michigan Alzheimer’s Disease Research Center. He is a member of
the Institute of Medicine of the National Academy of Sciences and a
past President of the American Neurological Association. He has also
held faculty and hospital appointments at Harvard Medical School
and Columbia Presbyterian Medical Center. His research is in vestibu
lar and cerebellar physiology and in the pathophysiological processes
underlying the cerebellar ataxias, Parkinson’s disease, the parkinsonian
syndromes and Alzheimer’s disease. He serves on numerous journal edi
torial boards and has published over 400 scientific papers, book chap
ters, and abstracts, including several co-authored or edited books.